Recent Landmark Trials

Volume 4, Jul 2015

Manish Bansal MD, DNB, Ravi R Kasliwal MD, DM, Gurgaon, India

Ezetimibe added to Statin Therapy after Acute Coronary Syndromes

IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trial

Cannon CP, et al. N Engl J Med 2015; 372: 2387-97

Trial summary

This multicentric trial evaluated whether incremental reduction in LDL-C achieved with a non-statin drug when added to statin therapy could produce incremental CV risk reduction also.

Volume 4, Number 3, Pages: 78-80